List of Tables
Table 1. Global Recombinant Human Coagulation Factor VIII for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Human Coagulation Factor VIII for Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Human Coagulation Factor VIII for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Human Coagulation Factor VIII for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Coagulation Factor VIII for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Human Coagulation Factor VIII for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Human Coagulation Factor VIII for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Coagulation Factor VIII for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Coagulation Factor VIII for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Coagulation Factor VIII for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Coagulation Factor VIII for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Coagulation Factor VIII for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Coagulation Factor VIII for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Human Coagulation Factor VIII for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Human Coagulation Factor VIII for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Human Coagulation Factor VIII for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Human Coagulation Factor VIII for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Human Coagulation Factor VIII for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Recombinant Human Coagulation Factor VIII for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Human Coagulation Factor VIII for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Human Coagulation Factor VIII for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Recombinant Human Coagulation Factor VIII for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Human Coagulation Factor VIII for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Coagulation Factor VIII for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Human Coagulation Factor VIII for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Recombinant Human Coagulation Factor VIII for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Recombinant Human Coagulation Factor VIII for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Coagulation Factor VIII for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Human Coagulation Factor VIII for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Recombinant Human Coagulation Factor VIII for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Recombinant Human Coagulation Factor VIII for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Recombinant Human Coagulation Factor VIII for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Recombinant Human Coagulation Factor VIII for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Recombinant Human Coagulation Factor VIII for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Human Coagulation Factor VIII for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Recombinant Human Coagulation Factor VIII for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Human Coagulation Factor VIII for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Human Coagulation Factor VIII for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Human Coagulation Factor VIII for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Recombinant Human Coagulation Factor VIII for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Recombinant Human Coagulation Factor VIII for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Recombinant Human Coagulation Factor VIII for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Human Coagulation Factor VIII for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Human Coagulation Factor VIII for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Human Coagulation Factor VIII for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Recombinant Human Coagulation Factor VIII for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Novo Nordisk A/S Company Information
Table 71. Novo Nordisk A/S Description and Business Overview
Table 72. Novo Nordisk A/S Recombinant Human Coagulation Factor VIII for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk A/S Recombinant Human Coagulation Factor VIII for Injection Product
Table 74. Novo Nordisk A/S Recent Developments/Updates
Table 75. Green Cross Corporation Company Information
Table 76. Green Cross Corporation Description and Business Overview
Table 77. Green Cross Corporation Recombinant Human Coagulation Factor VIII for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Green Cross Corporation Recombinant Human Coagulation Factor VIII for Injection Product
Table 79. Green Cross Corporation Recent Developments/Updates
Table 80. Bayer Company Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Recombinant Human Coagulation Factor VIII for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bayer Recombinant Human Coagulation Factor VIII for Injection Product
Table 84. Bayer Recent Developments/Updates
Table 85. CSL Behring Company Information
Table 86. CSL Behring Description and Business Overview
Table 87. CSL Behring Recombinant Human Coagulation Factor VIII for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. CSL Behring Recombinant Human Coagulation Factor VIII for Injection Product
Table 89. CSL Behring Recent Developments/Updates
Table 90. Shire (Takeda) Company Information
Table 91. Shire (Takeda) Description and Business Overview
Table 92. Shire (Takeda) Recombinant Human Coagulation Factor VIII for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Shire (Takeda) Recombinant Human Coagulation Factor VIII for Injection Product
Table 94. Shire (Takeda) Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Recombinant Human Coagulation Factor VIII for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Recombinant Human Coagulation Factor VIII for Injection Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Octapharma Company Information
Table 101. Octapharma Description and Business Overview
Table 102. Octapharma Recombinant Human Coagulation Factor VIII for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Octapharma Recombinant Human Coagulation Factor VIII for Injection Product
Table 104. Octapharma Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Recombinant Human Coagulation Factor VIII for Injection Distributors List
Table 108. Recombinant Human Coagulation Factor VIII for Injection Customers List
Table 109. Recombinant Human Coagulation Factor VIII for Injection Market Trends
Table 110. Recombinant Human Coagulation Factor VIII for Injection Market Drivers
Table 111. Recombinant Human Coagulation Factor VIII for Injection Market Challenges
Table 112. Recombinant Human Coagulation Factor VIII for Injection Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Recombinant Human Coagulation Factor VIII for Injection
Figure 2. Global Recombinant Human Coagulation Factor VIII for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Human Coagulation Factor VIII for Injection Market Share by Type: 2023 & 2030
Figure 4. 500IU/Bottle Product Picture
Figure 5. 1000IU/Bottle Product Picture
Figure 6. Global Recombinant Human Coagulation Factor VIII for Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Recombinant Human Coagulation Factor VIII for Injection Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Recombinant Human Coagulation Factor VIII for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Recombinant Human Coagulation Factor VIII for Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Recombinant Human Coagulation Factor VIII for Injection Sales (2019-2030) & (K Units)
Figure 14. Global Recombinant Human Coagulation Factor VIII for Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Recombinant Human Coagulation Factor VIII for Injection Report Years Considered
Figure 16. Recombinant Human Coagulation Factor VIII for Injection Sales Share by Manufacturers in 2023
Figure 17. Global Recombinant Human Coagulation Factor VIII for Injection Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Recombinant Human Coagulation Factor VIII for Injection Players: Market Share by Revenue in Recombinant Human Coagulation Factor VIII for Injection in 2023
Figure 19. Recombinant Human Coagulation Factor VIII for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Recombinant Human Coagulation Factor VIII for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Country (2019-2030)
Figure 42. Mexico Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Recombinant Human Coagulation Factor VIII for Injection Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Recombinant Human Coagulation Factor VIII for Injection Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Recombinant Human Coagulation Factor VIII for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Recombinant Human Coagulation Factor VIII for Injection by Type (2019-2030)
Figure 52. Global Revenue Market Share of Recombinant Human Coagulation Factor VIII for Injection by Type (2019-2030)
Figure 53. Global Recombinant Human Coagulation Factor VIII for Injection Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Recombinant Human Coagulation Factor VIII for Injection by Application (2019-2030)
Figure 55. Global Revenue Market Share of Recombinant Human Coagulation Factor VIII for Injection by Application (2019-2030)
Figure 56. Global Recombinant Human Coagulation Factor VIII for Injection Price (US$/Unit) by Application (2019-2030)
Figure 57. Recombinant Human Coagulation Factor VIII for Injection Value Chain
Figure 58. Recombinant Human Coagulation Factor VIII for Injection Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
